Ulrika Hammarström appointed new Head of CRO
Last year, Aurevia (formerly LabQuality) acquired Scandinavian CRO. Recently, Ulrika Hammarström, Founder and CEO of Scandinavian CRO, has been appointed as the new Head of the CRO business area for Aurevia. She assumes the CRO business area head position in Aurevia and will lead the international Aurevia CRO (Contract Research Organization) team. In Sweden, Scandinavian CRO and QAdvis are part of Aurevia, and the company has professional CRO teams also in Poland, Germany, and Finland.
Aurevia’s CRO team offers international clinical trial services for pharmaceutical, biotech, and medical device companies, as well as academia.
Ulrika is the Founder and CEO of Scandinavian CRO in Sweden. In 2024, Ulrika was chosen as the local and regional Entrepreneur of the Year, as well as an EY Entrepreneur of the Year Finalist at the national level.
Ulrika is now a member of the Aurevia Management team, reporting to Aurevia CEO Juha-Pekka Nuutinen.
“It is my pleasure to welcome Ulrika to the Aurevia team. She will contribute to Aurevia’s CRO business development and growth with her solid leadership experience and knowledge of CRO operations. Ulrika will build and strengthen our CRO offering and geographical coverage to position Aurevia as the full-service European CRO provider. Additionally, we share the same passion for quality excellence in healthcare,” says CEO Juha-Pekka Nuutinen from Aurevia.
“I’m thrilled to join the Aurevia team and look forward to expanding our CRO business. Our team of highly skilled experts have decades of experience working in clinical research, and together with our quality assurance and regulatory affairs (QARA) colleagues, we can support our clients throughout their product development lifecycle. Ultimately, the goal is to provide patients with better outcomes and quality of life,” concludes Ulrika Hammarström.
